Improving drug tolerability is the cornerstone of our research strategy
Treatment-associated side effects have a significant impact on quality of life and treatment adherence.
In the context of a life-long medical condition such as IBD, addressing potential tolerability issues becomes even more critical.
Giiant Pharma: We Make Small Molecules